0001209191-17-039574.txt : 20170613
0001209191-17-039574.hdr.sgml : 20170613
20170613172341
ACCESSION NUMBER: 0001209191-17-039574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170612
FILED AS OF DATE: 20170613
DATE AS OF CHANGE: 20170613
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Audentes Therapeutics, Inc.
CENTRAL INDEX KEY: 0001628738
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461606174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 415-638-6556
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jarrett Jennifer
CENTRAL INDEX KEY: 0001671311
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37833
FILM NUMBER: 17909689
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 525 MARKET ST., 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-12
0
0001628738
Audentes Therapeutics, Inc.
BOLD
0001671311
Jarrett Jennifer
C/O AUDENTES THERAPEUTICS, INC.
600 CALIFORNIA STREET, 17TH FLOOR
SAN FRANCISCO
CA
94108
1
0
0
0
Stock Option (right to buy)
14.70
2017-06-12
4
A
0
18000
0.00
A
2027-06-12
Common Stock
18000
18000
D
The option vests as to 2.777% of the total shares monthly, beginning on July 12, 2017, with 100% of the total shares vested and exercisable on June 12, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Thomas Soloway as attorney-in-fact for Jennifer Jarrett
2017-06-13